Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Lancet Oncol. 2019 May 28;20(7):1011–1022. doi: 10.1016/S1470-2045(19)30277-3

Figure 2.

Figure 2

Figure 2

Figure 2

Kaplan-Meir curve representing progression-free survival of patients from the dates on treatment to dates of tumor progression, death, or last contact (95% CI) for stratum 1 (A), stratum 3 (B) and based on specific BRAF aberration in stratum 1 (C).